Humana (HUM)

HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.

GE HealthCare is among S&P 500 leaders and Humana among the laggards after both beat Q2 forecasts. Both stocks are near key levels.

Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-G...

Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM

Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know. Humana met analy...

Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company

UNH stock surged past a buy point, leading the Dow Jones, after Q2 earnings trounced estimates amid lower-than-expected benefit costs.

Top healthcare insurance stocks like UNH, CVS, and Humana stocks are rising after the Medicare advantage payment hike and analysts are taking note.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:H...

The "Mad Money" host says, "Buy it." Should you listen?

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.

The hard-earned dollars you park in a standard S&P 500 index fund may not be distributed the way you think they are.

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...